Leaders in cancer radiotherapy recognize World Cancer Day through Elekta brachytherapy equipment donation
Four Elekta (EKTA-B.ST) high-dose radiation (HDR) brachytherapy units are being donated to Radiating Hope, a non-profit organization with a mission to improve radiation oncology care around the globe. The donation, being made directly by Gamma West Cancer Services (Utah, U.S.), is being announced in concert with World Cancer Day, which is observed annually on February 4 and is designed to draw attention to what can be done to address cancer.
Radiating Hope plans to deploy the four HDR brachytherapy units in Nepal. HDR brachytherapy is a powerful method for delivering radiation internally to target cancer tissues, and is used in the treatment of skin, cervical, prostate and breast cancer.
“While 60-70 percent of U.S. cancer patients receive radiation therapy as part of their treatment, most people in developing countries don’t have access to this life-saving care, largely due to limited access to radiation equipment,” says Tom Ladd, Executive Director. “Radiating Hope is committed to ensuring that there is at least one radiation therapy device for every 100,000-200,000 people – the current standard in the United States – in developing countries. This generous donation will help to further our efforts to meet this goal in Nepal, and we thank Elekta for their support.”
“Worldwide, more than eight million people die from cancer each year and many people in developing countries have limited access to safe and effective cancer treatments,” says Bill Yaeger, Elekta’s Executive Vice President, Region North America. “Elekta is committed to expanding access to our radiation therapy devices and systems in areas with high unmet medical needs. We are proud to support Radiating Hope, an organization with a demonstrated track record in improving access to radiation oncology technologies around the world, and are pleased to help support the delivery of urgently needed medical equipment to Nepal.”
More than 26 million people live in Nepal, yet the country has only three radiation oncology centers and four radiation therapy devices. The donation of the four Elekta HDR brachytherapy units will double the number of radiation therapy devices, which is expected to provide increased access to care to a significant number of Nepalese cancer patients.
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, Email: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager
Tel: +1 770 670 2524, Email: raven.canzeri@elekta.com
Time zone: EST: Eastern Standard Time
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com Twitter: @Elekta.